Daiwa Securities Group Inc.
Broker-DealerPosition in IBRX — ImmunityBio, Inc.
CIK 1481045
CHIYODA-KU,TOKYO, M0
Position in IBRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,527,864
+$1,521,582 QoQ
Shares Held
199,200
+6178.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,527,864
PutShares
199,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Daiwa Securities Group Inc. holds $105,367,050 across 28 Biotechnology names. IBRX ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,539 | $30,158,865 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,525 | $28,220,675 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,364 | $8,392,185 | |
| 4 | TECH |
BIO-TECHNE Corp
|
145,000 | $7,577,699 | |
| 5 | INSM |
INSMED Inc
|
39,429 | $6,447,430 | |
| 6 | INCY |
Incyte Corp
|
39,366 | $3,705,127 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
15,000 | $2,835,750 | |
| 8 | RPRX |
Royalty Pharma plc
|
41,827 | $2,006,441 |
All Filings in IBRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,527,864 | 199,200 | Put | Defined | 2026-05-13 | |
| 2026-03-31 | $1,527,864 | 199,200 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,282 | 3,173 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,805 | 3,173 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,376 | 3,173 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,886 | 2,620 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,707 | 2,620 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,746 | 2,620 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,558 | 2,620 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $14,660 | 2,730 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $13,704 | 2,730 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,720 | 1,610 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,475 | 1,610 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,930 | 1,610 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $8,162 | 1,610 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $7,370 | 1,483 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $95,191 | 25,589 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $125,843 | 22,432 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $95,796 | 15,756 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $56,686 | 5,820 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $10,652 | 746 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $5,127 | 216 | Shares | Sole | 2021-05-03 | |
| No filing history on record for this holder in this stock. | ||||||